EUVIMEDEUVIMED entdecken
Crossref

YWHAG mediated epithelial-mesenchymal transition facilitates tumor progression and metastatic spread in non-small cell lung cancer

Kai Liu, Huiyong Han, Sha Huang, Lijiang Song, Jiuzhou Jiang, Dawei Zheng

Cellular Signalling · 2025

DOI: 10.1016/j.cellsig.2025.112139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Kai Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 31000, Zhejiang Province, China.. Electr…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, 14-3-3 Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: YWHAG, a 14-3-3 protein family member, has been implicated in tumorigenesis, yet its role in lung cancer progression and underlying mechanisms remain poorly understood. This study aimed to elucidate the functional and mechanistic contributions of YWHAG to non-small cell lung cancer (NSCLC). METHODS: Multi-omics analyses were performed using TCGA pan-cancer datasets, NSCLC single-cell RNA sequencing (scRNA-seq) data (GSE117570 & GSE148071), and public NSCLC mouse models. Functional validation included in vitro siRNA knockdown and overexpression of YWHAG in NCI-H292 cells, co-immunoprecipitation (Co-IP), immunofluorescence, and pathway activity assays. A lung-specific YWHAG knockout mouse model was generated using AAV5-SPC-Cre, and tumor growth/metastasis were assessed in an orthotopic A549 cell-derived NSCLC model via bioluminescence imaging and histopathology. RESULTS: YWHAG was significantly upregulated across 29 cancer types, including lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC), and correlated with poor patient survival. scRNA-seq revealed YWHAG-enriched proliferating epithelial cells (ECs) with elevated EMT activity (EMT_AUC score), marked by upregulation of COL12A1, FN1, and YWHAG. Mechanistically, YWHAG knockdown suppressed EMT (increased E-cadherin, decreased N-cadherin/Vimentin), proliferation, and migration, while overexpression exerted opposite effects. YWHAG interacted with LRRK2 to activate the PI3K/AKT pathway, and LRRK2 overexpression rescued PI3K/AKT suppression post-YWHAG knockdown. In mice, lung-specific YWHAG knockout attenuated tumor growth and metastasis, suppressed EMT markers, and reduced metastatic burden in lung, liver, and skeletal muscle. CONCLUSION: YWHAG drives NSCLC progression by promoting EMT, proliferation, and metastasis via the LRRK2/PI3K/AKT axis. Its pan-cancer overexpression and prognostic significance highlights YWHAG as a promising therapeutic target in lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionCarcinoma, Non-Small-Cell LungLung Neoplasms14-3-3 ProteinsHumansAnimalsMiceDisease ProgressionNeoplasm MetastasisCell Line, TumorCell ProliferationCell MovementGene Expression Regulation, NeoplasticMice, KnockoutA549 CellsProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

Epithelial-to-mesenchymal transitionNon-small cell lung cancerPI3K/AKT pathwaySingle-cell RNA sequencingYWHAG

Substanzen

14-3-3 ProteinsProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 31000, Zhejiang Province, China.. Electronic address: liukai720@zju.edu.cn.
  • Department of Thoracic Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 31000, Zhejiang Province, China.
  • Department of Thoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo 315000, Zhejiang Province, China.. Electronic address: lhlzhengdawei@nbu.edu.cn.

Zitieren

APA

Liu, K., Han, H., Huang, S., Song, L., Jiang, J., & Zheng, D. (2025). YWHAG mediated epithelial-mesenchymal transition facilitates tumor progression and metastatic spread in non-small cell lung cancer. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112139

Vancouver

Liu K, Han H, Huang S, Song L, Jiang J, Zheng D. YWHAG mediated epithelial-mesenchymal transition facilitates tumor progression and metastatic spread in non-small cell lung cancer. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112139

BibTeX
@article{Liu2025,
  author = {Liu, Kai and Han, Huiyong and Huang, Sha and Song, Lijiang and Jiang, Jiuzhou and Zheng, Dawei},
  title = {YWHAG mediated epithelial-mesenchymal transition facilitates tumor progression and metastatic spread in non-small cell lung cancer},
  journal = {Cellular Signalling},
  year = {2025},
  doi = {10.1016/j.cellsig.2025.112139}
}
Kostenlos starten →